Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 248 of 248 entries
Sorted by: Best Match Show Resources per page
Physician perspectives on placebo ethics.

Journal of medical ethics

Bliamptis J, Barnhill A.
PMID: 34257086
J Med Ethics. 2021 Jul 13; doi: 10.1136/medethics-2021-107446. Epub 2021 Jul 13.

Clinical use of placebos is controversial among bioethicists. While placebos have been shown to provide benefit for patients with some conditions, offering placebos to patients without disclosing that they are placebos raises ethical concerns, including the concern that this...

Cite
Bliamptis J, Barnhill A. Physician perspectives on placebo ethics. J Med Ethics. 2021;doi: 10.1136/medethics-2021-107446.
Bliamptis, J., & Barnhill, A. (2021). Physician perspectives on placebo ethics. Journal of medical ethics, . https://doi.org/10.1136/medethics-2021-107446
Bliamptis, John, and Barnhill, Anne. "Physician perspectives on placebo ethics." Journal of medical ethics vol. (2021). doi: https://doi.org/10.1136/medethics-2021-107446
Bliamptis J, Barnhill A. Physician perspectives on placebo ethics. J Med Ethics. 2021 Jul 13; doi: 10.1136/medethics-2021-107446. Epub 2021 Jul 13. PMID: 34257086.
Copy Download .nbib Format: NLM
Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review.

Pharmaceuticals (Basel, Switzerland)

Main BJ, Maffulli N, Valk JA, Rodriguez HC, Gupta M, El-Amin SF, Gupta A.
PMID: 34832872
Pharmaceuticals (Basel). 2021 Oct 27;14(11). doi: 10.3390/ph14111090.

Musculoskeletal ailments affect millions of people around the world and place a high burden on healthcare. Traditional treatment modalities are limited and do not address underlying pathologies. Mesenchymal stem cells (MSCs) have emerged as an exciting therapeutic alternative and...

Cite
Main BJ, Maffulli N, Valk JA, et al. Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review. Pharmaceuticals (Basel). 2021;14(11)doi: 10.3390/ph14111090.
Main, B. J., Maffulli, N., Valk, J. A., Rodriguez, H. C., Gupta, M., El-Amin, S. F., & Gupta, A. (2021). Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review. Pharmaceuticals (Basel, Switzerland), 14(11), . https://doi.org/10.3390/ph14111090
Main, Benjamin J, et al. "Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review." Pharmaceuticals (Basel, Switzerland) vol. 14,11 (2021). doi: https://doi.org/10.3390/ph14111090
Main BJ, Maffulli N, Valk JA, Rodriguez HC, Gupta M, El-Amin SF, Gupta A. Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review. Pharmaceuticals (Basel). 2021 Oct 27;14(11). doi: 10.3390/ph14111090. PMID: 34832872; PMCID: PMC8618385.
Copy Download .nbib Format: NLM
Placebos in clinical care: a suggestion beyond the evidence.

The Medical journal of Australia

Maher CG, Traeger AC, Abdel Shaheed C, O'Keeffe M.
PMID: 34537963
Med J Aust. 2021 Sep 19; doi: 10.5694/mja2.51230. Epub 2021 Sep 19.

No abstract available.

Cite
Maher CG, Traeger AC, Abdel Shaheed C, et al. Placebos in clinical care: a suggestion beyond the evidence. Med J Aust. 2021;doi: 10.5694/mja2.51230.
Maher, C. G., Traeger, A. C., Abdel Shaheed, C., & O'Keeffe, M. (2021). Placebos in clinical care: a suggestion beyond the evidence. The Medical journal of Australia, . https://doi.org/10.5694/mja2.51230
Maher, Christopher G, et al. "Placebos in clinical care: a suggestion beyond the evidence." The Medical journal of Australia vol. (2021). doi: https://doi.org/10.5694/mja2.51230
Maher CG, Traeger AC, Abdel Shaheed C, O'Keeffe M. Placebos in clinical care: a suggestion beyond the evidence. Med J Aust. 2021 Sep 19; doi: 10.5694/mja2.51230. Epub 2021 Sep 19. PMID: 34537963.
Copy Download .nbib Format: NLM
In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses.

Infectious diseases and therapy

Shet M, Hong R, Igo D, Cataldo M, Bhaskar S.
PMID: 34581973
Infect Dis Ther. 2021 Dec;10(4):2777-2790. doi: 10.1007/s40121-021-00536-1. Epub 2021 Sep 28.

INTRODUCTION: Polyvinylpyrrolidone-iodine (PVP-I) demonstrates broad-spectrum anti-infective activity and is available in different formulations for oral rinse and topical use in medical and personal care settings. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has underscored the need to...

Cite
Shet M, Hong R, Igo D, et al. In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses. Infect Dis Ther. 2021;10(4):2777-2790doi: 10.1007/s40121-021-00536-1.
Shet, M., Hong, R., Igo, D., Cataldo, M., & Bhaskar, S. (2021). In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses. Infectious diseases and therapy, 10(4), 2777-2790. https://doi.org/10.1007/s40121-021-00536-1
Shet, Manjunath, et al. "In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses." Infectious diseases and therapy vol. 10,4 (2021): 2777-2790. doi: https://doi.org/10.1007/s40121-021-00536-1
Shet M, Hong R, Igo D, Cataldo M, Bhaskar S. In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses. Infect Dis Ther. 2021 Dec;10(4):2777-2790. doi: 10.1007/s40121-021-00536-1. Epub 2021 Sep 28. PMID: 34581973; PMCID: PMC8477977.
Copy Download .nbib Format: NLM
Evidence for the additive effects of dispositional negative mood regulation expectancies and placebo-induced expectancies on mood recovery.

Journal of personality

Bailey VS, Brown CM.
PMID: 33999414
J Pers. 2021 Dec;89(6):1223-1231. doi: 10.1111/jopy.12646. Epub 2021 Jun 01.

OBJECTIVE: Low negative mood regulation expectancies (NMRE) are associated with greater anticipated and experienced negative mood states, as well as with coping strategies that prolong these states. Individuals with low NMRE may be especially responsive to placebos because confidence...

Cite
Bailey VS, Brown CM. Evidence for the additive effects of dispositional negative mood regulation expectancies and placebo-induced expectancies on mood recovery. J Pers. 2021;89(6):1223-1231doi: 10.1111/jopy.12646.
Bailey, V. S., & Brown, C. M. (2021). Evidence for the additive effects of dispositional negative mood regulation expectancies and placebo-induced expectancies on mood recovery. Journal of personality, 89(6), 1223-1231. https://doi.org/10.1111/jopy.12646
Bailey, Veronika S, and Brown, Christina M. "Evidence for the additive effects of dispositional negative mood regulation expectancies and placebo-induced expectancies on mood recovery." Journal of personality vol. 89,6 (2021): 1223-1231. doi: https://doi.org/10.1111/jopy.12646
Bailey VS, Brown CM. Evidence for the additive effects of dispositional negative mood regulation expectancies and placebo-induced expectancies on mood recovery. J Pers. 2021 Dec;89(6):1223-1231. doi: 10.1111/jopy.12646. Epub 2021 Jun 01. PMID: 33999414.
Copy Download .nbib Format: NLM
Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.

PLoS medicine

DeBoer MD, Platts-Mills JA, Elwood SE, Scharf RJ, McDermid JM, Wanjuhi AW, Jatosh S, Katengu S, Parpia TC, Rogawski McQuade ET, Gratz J, Svensen E, Swann JR, Donowitz JR, Mdoe P, Kivuyo S, Houpt ER, Mduma E.
PMID: 34582462
PLoS Med. 2021 Sep 28;18(9):e1003617. doi: 10.1371/journal.pmed.1003617. eCollection 2021 Sep.

BACKGROUND: Stunting among children in low-resource settings is associated with enteric pathogen carriage and micronutrient deficiencies. Our goal was to test whether administration of scheduled antimicrobials and daily nicotinamide improved linear growth in a region with a high prevalence...

Cite
DeBoer MD, Platts-Mills JA, Elwood SE, et al. Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial. PLoS Med. 2021;18(9):e1003617doi: 10.1371/journal.pmed.1003617.
DeBoer, M. D., Platts-Mills, J. A., Elwood, S. E., Scharf, R. J., McDermid, J. M., Wanjuhi, A. W., Jatosh, S., Katengu, S., Parpia, T. C., Rogawski McQuade, E. T., Gratz, J., Svensen, E., Swann, J. R., Donowitz, J. R., Mdoe, P., Kivuyo, S., Houpt, E. R., & Mduma, E. (2021). Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial. PLoS medicine, 18(9), e1003617. https://doi.org/10.1371/journal.pmed.1003617
DeBoer, Mark D, et al. "Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial." PLoS medicine vol. 18,9 (2021): e1003617. doi: https://doi.org/10.1371/journal.pmed.1003617
DeBoer MD, Platts-Mills JA, Elwood SE, Scharf RJ, McDermid JM, Wanjuhi AW, Jatosh S, Katengu S, Parpia TC, Rogawski McQuade ET, Gratz J, Svensen E, Swann JR, Donowitz JR, Mdoe P, Kivuyo S, Houpt ER, Mduma E. Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial. PLoS Med. 2021 Sep 28;18(9):e1003617. doi: 10.1371/journal.pmed.1003617. eCollection 2021 Sep. PMID: 34582462; PMCID: PMC8478246.
Copy Download .nbib Format: NLM
Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?.

Sleep medicine

Perlis ML, Morales KH, Vargas I, Muench A, Seewald M, Gooneratne N, Grandner MA, Thase ME, Kaptchuk TJ, Ader R.
PMID: 34509775
Sleep Med. 2021 Nov;87:56-61. doi: 10.1016/j.sleep.2021.04.041. Epub 2021 Aug 21.

BACKGROUND: Previous research has shown that after one month of full dose nightly treatment with zolpidem (priming), subjects with chronic insomnia (CI) switched to intermittent dosing with medication and placebos were able to maintain their treatment responses. This approach...

Cite
Perlis ML, Morales KH, Vargas I, et al. Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?. Sleep Med. 2021;87:56-61doi: 10.1016/j.sleep.2021.04.041.
Perlis, M. L., Morales, K. H., Vargas, I., Muench, A., Seewald, M., Gooneratne, N., Grandner, M. A., Thase, M. E., Kaptchuk, T. J., & Ader, R. (2021). Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?. Sleep medicine, 8756-61. https://doi.org/10.1016/j.sleep.2021.04.041
Perlis, Michael L, et al. "Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?." Sleep medicine vol. 87 (2021): 56-61. doi: https://doi.org/10.1016/j.sleep.2021.04.041
Perlis ML, Morales KH, Vargas I, Muench A, Seewald M, Gooneratne N, Grandner MA, Thase ME, Kaptchuk TJ, Ader R. Durability of treatment response to zolpidem using a partial reinforcement regimen: does this strategy require priming?. Sleep Med. 2021 Nov;87:56-61. doi: 10.1016/j.sleep.2021.04.041. Epub 2021 Aug 21. PMID: 34509775.
Copy Download .nbib Format: NLM
Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial.

Trials

Jiang RC, Wang D, Zhao SG, Wang RZ, Kang Z, Zhu XG, Zhao ZM, Wei JJ, Huang Y, Qu Y, Sun XC, Ji HM, Jiang XC, Liu JF, De Zhu X, Wang JJ, Tian Y, Gao C, Wei HJ, Zhang S, Quan W, Yue SY, Lei P, Li X, Song LL, Anderson CS, Zhang JN.
PMID: 34895306
Trials. 2021 Dec 11;22(1):905. doi: 10.1186/s13063-021-05871-9.

BACKGROUND: Chronic subdural haematoma (CSDH) is a common condition in the elderly that often requires neurosurgical management. For small CSDH, evidence has emerged that statins may reduce haematoma volume and improve outcomes, presumably by reducing local inflammation and promoting...

Cite
Jiang RC, Wang D, Zhao SG, et al. Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial. Trials. 2021;22(1):905doi: 10.1186/s13063-021-05871-9.
Jiang, R. C., Wang, D., Zhao, S. G., Wang, R. Z., Kang, Z., Zhu, X. G., Zhao, Z. M., Wei, J. J., Huang, Y., Qu, Y., Sun, X. C., Ji, H. M., Jiang, X. C., Liu, J. F., De Zhu, X., Wang, J. J., Tian, Y., Gao, C., Wei, H. J., Zhang, S., Quan, W., Yue, S. Y., Lei, P., Li, X., Song, L. L., Anderson, C. S., & Zhang, J. N. (2021). Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial. Trials, 22(1), 905. https://doi.org/10.1186/s13063-021-05871-9
Jiang, Rong Cai, et al. "Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial." Trials vol. 22,1 (2021): 905. doi: https://doi.org/10.1186/s13063-021-05871-9
Jiang RC, Wang D, Zhao SG, Wang RZ, Kang Z, Zhu XG, Zhao ZM, Wei JJ, Huang Y, Qu Y, Sun XC, Ji HM, Jiang XC, Liu JF, De Zhu X, Wang JJ, Tian Y, Gao C, Wei HJ, Zhang S, Quan W, Yue SY, Lei P, Li X, Song LL, Anderson CS, Zhang JN. Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial. Trials. 2021 Dec 11;22(1):905. doi: 10.1186/s13063-021-05871-9. PMID: 34895306.
Copy Download .nbib Format: NLM
Showing 241 to 248 of 248 entries